Petra Schuberth
Impact in
- Oncology top 10%
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
-
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
Papers in
- Oncology 10
- CAR-T cell therapy research 8
- Peptidase Inhibition and Analysis 3
- Cancer Treatment and Pharmacology 1
-
- Immunotherapy and Immune Responses 2
- Co-authors
- Christoph Renner (5 shared papers)Ulf Petrausch (5 shared papers)Rolf A. Stahel (2 shared papers)Alex Soltermann (2 shared papers)Axel Mischo (3 shared papers)Shawn M. Jensen (2 shared papers)Norbert Koch (1 shared paper)Maries van den Broek (2 shared papers)
- Journals
- Journal of Translational Medicine (1 paper)Journal of Clinical Oncology (1 paper)The Journal of Immunology (1 paper)BMC Cancer (1 paper)Gene Therapy (1 paper)
- Partner nations
- SwitzerlandUnited StatesGermany
In The Last Decade
Petra Schuberth
9 papers receiving 443 citations
Peers
Comparison fields: 5 of 41
- Oncology 289
- Immunology 140
- Cancer Research 78
- Genetics 81
- Molecular Biology 185
Countries citing papers authored by Petra Schuberth
This map shows the geographic impact of Petra Schuberth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petra Schuberth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petra Schuberth more than expected).
Fields of papers citing papers by Petra Schuberth
This network shows the impact of papers produced by Petra Schuberth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petra Schuberth. The network helps show where Petra Schuberth may publish in the future.
Co-authors
The 25 scholars most cited alongside Petra Schuberth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 159 | |
| 2 | 2008 | 125 | |
| 3 | 2012 | 64 | |
| 4 | 2012 | 49 | |
| 5 | 2022 | 26 | |
| 6 | 2015 | 9 | |
| 7 | 2022 | 7 | |
| 8 | Antigen-specific in vitro expansion of functional redirected NY-ESO-1-specific human CD8+ T-cells in a cell-free system. | 2013 | 6 |
| 9 | 2023 | 1 | |
| 10 | 2024 | 0 | |
| 11 | 2024 | 0 |
About Petra Schuberth
Petra Schuberth is a scholar working on Oncology, Immunology, Surgery, Molecular Biology and Hematology, having authored 11 papers that have together received 446 indexed citations. Recurring topics across this work include CAR-T cell therapy research (8 papers), Peptidase Inhibition and Analysis (3 papers), Cardiac Structural Anomalies and Repair (2 papers), Multiple Myeloma Research and Treatments (2 papers), Immunotherapy and Immune Responses (2 papers), Cancer Treatment and Pharmacology (1 paper), Signaling Pathways in Disease (1 paper) and Chronic Myeloid Leukemia Treatments (1 paper). The work is most often cited by research in Oncology (289 citations), Immunology (140 citations), Cancer Research (78 citations), Genetics (81 citations) and Molecular Biology (185 citations). Petra Schuberth has collaborated with scholars based in Switzerland, United States and Germany. Frequent co-authors include Christoph Renner, Ulf Petrausch, Rolf A. Stahel, Alex Soltermann, Axel Mischo, Shawn M. Jensen, Norbert Koch, Maries van den Broek, Sarah C. Saunderson and Ralph W. Jack. Their work appears in journals such as Journal of Translational Medicine, Journal of Clinical Oncology, The Journal of Immunology, BMC Cancer and Gene Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.